Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes.

ACS Infect Dis 2016 11 7;2(11):816-826. Epub 2016 Apr 7.

Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health , Boston, Massachusetts 02115, United States.

MMV007564 is a novel antimalarial benzimidazolyl piperidine chemotype identified in cellular screens. To identify the genetic determinant of MMV007564 resistance, parasites were cultured in the presence of the compound to generate resistant lines. Whole genome sequencing revealed distinct mutations in the gene named Plasmodium falciparum cyclic amine resistance locus (pfcarl), encoding a conserved protein of unknown function. Mutations in pfcarl are strongly associated with resistance to a structurally unrelated class of compounds, the imidazolopiperazines, including KAF156, currently in clinical trials. Our data demonstrate that pfcarl mutations confer resistance to two distinct compound classes, benzimidazolyl piperidines and imidazolopiperazines. However, MMV007564 and the imidazolopiperazines, KAF156 and GNF179, have different timings of action in the asexual blood stage and different potencies against the liver and sexual blood stages. These data suggest that pfcarl is a multidrug-resistance gene rather than a common target for benzimidazolyl piperidines and imidazolopiperazines.

Download full-text PDF

Source
http://pubs.acs.org/doi/10.1021/acsinfecdis.6b00025
Publisher Site
http://dx.doi.org/10.1021/acsinfecdis.6b00025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109296PMC
November 2016
58 Reads

Publication Analysis

Top Keywords

locus pfcarl
8
resistance locus
8
distinct compound
8
compound classes
8
benzimidazolyl piperidines
8
amine resistance
8
piperidines imidazolopiperazines
8
cyclic amine
8
falciparum cyclic
8
plasmodium falciparum
8
resistance
6
pfcarl
5
compounds imidazolopiperazines
4
imidazolopiperazines including
4
class compounds
4
unrelated class
4
imidazolopiperazines
4
currently clinical
4
trials data
4
data demonstrate
4

Similar Publications